ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

7.18
0.04
(0.56%)
Closed February 18 3:00PM
7.18
0.00
( 0.00% )
Pre Market: 3:00AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.29M2.47M2.72M77.97M7.9M8.65M11.87M12.82M
Operating Income -155.47M-170.46M-211.85M-42.07M-117.68M-111.3M-101.2M-102.19M
Pre Tax Income -146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M-95.78M
Net Income -146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M-95.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -155.66M-170.5M-211.9M-42.17M-117.69M-111.3M-101.19M-102.18M
EBITDA -155.15M-170.13M-211.52M-41.67M-117.34M-110.99M-100.95M-102.07M
Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 090.27M6.87M1.11B6.31M7.69M86.46M41.24M
Operating Income -273.16M-393.24M-708.12M596.23M-460.91M-546.99M-579.85M-432.37M
Pre Tax Income -270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M-400.67M
Net Income -270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M-400.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -6.431-7.953-13.11310.394-7.769-8.953-9.03-6.55
EBIT -273.22M-393.22M-708.04M596.48M-460.78M-546.97M-580.23M-432.34M
EBITDA -272.62M-392.1M-705.84M598.86M-456.73M-545.87M-578.46M-431.34M